COMMUNIQUÉS West-GlobeNewswire

UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
03/11/2026
Supported The Michael J Fox Foundation for Parkinson's Research, Alzheimer's Research UK and LifeArc, the study targets earlier detection, prevention and treatment of Parkinson’s disease, Alzheimer’s disease and other [...]
J-Star Holding Co., Ltd. Receives Shareholder Approval for Capital Restructuring and Reinforces Strategic Focus on U.S. Growth
02/11/2026
TAICHUNG, Taiwan and HOUSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), an innovator in advanced composite manufacturing, today announced that shareholders [...]
Vireo Growth Inc. Receives Federal DEA Registrations for Florida Medical Cannabis Dispensaries
02/11/2026
MINNEAPOLIS, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), a leading cannabis company and agricultural markets platform, today announced that it has received [...]
Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026
02/11/2026
Fort Lee, NJ, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/11/2026
SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/11/2026
NEW YORK and WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the [...]
Opus Genetics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
02/11/2026
RESEARCH TRIANGLE PARK, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients [...]
MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
02/11/2026
Webcast to highlight advancement of the randomized Phase 2 trial of agenT-797 in acute lung injury, the ARPA-H collaboration to advance deployable cell therapeutics, and new data released at the Society for [...]
Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair
02/11/2026
New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in FAP, with activity throughout the GI tract and in larger, higher-risk [...]
DBV Technologies to Participate in Upcoming November Investor Conferences
02/11/2026
Châtillon, France, November 2, 2026 DBV Technologies to Participate in Upcoming November Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a late- [...]
DBV Technologies participera aux prochaines Conférences Investisseurs en novembre
02/11/2026
Châtillon, France, le 2 novembre (22 :30 CEST) 2026 DBV Technologies participera aux prochaines Conférences Investisseurs en novembre DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT [...]
Olema Oncology to Participate in Upcoming Investor Conferences
02/11/2026
SAN FRANCISCO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
02/11/2026
Third quarter revenue of $206.7 million Third quarter diluted EPS of $(0.84); adjusted diluted EPS of $0.14 Third quarter operating cash flow of $46.4 million AMA CPT® Editorial Panel approved new Category I CPT codes [...]
Medline announces participation in the 2026 Jefferies Global Healthcare Conference
02/11/2026
NORTHFIELD, Ill., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, chief executive officer, is scheduled to present at the Jefferies Global Healthcare Conference [...]
Intuitive Appoints Aaron Martin to its Board of Directors
02/11/2026
SUNNYVALE, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the appointment of Aaron [...]
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue Guidance
02/11/2026
Delivered ~20 % U.S. procedure volume growth in the third quarter Third Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $55.7 million, representing growth of 14.5% U [...]
Abivax to Participate in Upcoming Fall Investor Conferences
02/11/2026
Abivax to Participate in Upcoming Fall Investor Conferences PARIS, France – November 2, 2026 – 10:05 PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage [...]
Abivax participera à plusieurs conférences investisseurs cet automne
02/11/2026
Abivax participera à plusieurs conférences investisseurs cet automne PARIS, France – le 2 novembre 2026 – 22 h 05 CET – Abivax SA (Euronext Paris : FR0012333284 – ABVX / Nasdaq: ABVX) (« Abivax » ou la « Société »), [...]
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
02/11/2026
SALT LAKE CITY, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three [...]

Pages